Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial - Wikidata - wikimedia - TriplyDB

Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial

Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial

http://www.wikidata.org/entity/Q37042040

about

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients Management of hyperphosphataemia in chronic kidney disease: summary of National Institute for Health and Clinical Excellence (NICE) guideline Lanthanum carbonate: safety data after 10 years Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China.Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate.A comparison of the long-term effects of lanthanum carbonate and calcium carbonate on the course of chronic renal failure in rats with adriamycin-induced nephropathy Klotho and kidney disease.Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis.Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.The adequacy of phosphorus binder prescriptions among American hemodialysis patients.Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.Contribution of food additives to sodium and phosphorus content of diets rich in processed foods.Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD.CKD-mineral and bone disorder: core curriculum 2011.Diseases of the parathyroid gland in chronic kidney disease.Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate.Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children.Hyperparathyroidism in chronic kidney disease patients: an update on current pharmacotherapy.Hyperphosphataemia: treatment options.Effects and safety of lanthanum carbonate in end stage renal disease patients with hyperphosphatemia: a meta-analysis--system review of lanthanum carbonate.Encephalopathy caused by lanthanum carbonate Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial.The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D.Lanthanum carbonate prevents accelerated medial calcification in uremic rats: role of osteoclast-like activity.Phosphorus metabolism in chronic kidney disease.Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.Phosphate Metabolism in CKD Stages 3-5: Dietary and Pharmacological Control.Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.Approach to cardiovascular disease prevention in patients with chronic kidney disease.Changes With Lanthanum Carbonate, Calcium Acetate, and Phosphorus Restriction in CKD: A Randomized Controlled Trial.The utility of the phosphate binder, ferric citrate hydrate (JTT-751), about phosphorus absorption-reducing effect in normal rats Non-calcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects

P2860

Q24234036-AFAFC847-87BB-4A29-B882-4F5D17192ABA Q26866391-5DE3A796-03C0-4E63-B16F-EB72B88445CC Q28079982-149A861C-17C9-4110-A8FB-0F6E46B98A6B Q33770086-0886D846-A6C2-478B-8C16-BBE41C2C8747 Q33821566-296C77DB-06E7-4838-BD79-1EC6EEF39F2F Q34573734-DFE62AEB-7F62-4C02-90EA-99F13D19A436 Q35026657-2B16B4BB-E4A6-4677-BB8C-BBB90E0EE79E Q35171681-59D1BA4D-0063-4EDB-9FC9-4552FF6E16FE Q35582566-F9778863-A9EB-4EEE-A3D1-DB1FE62B9B2D Q35743692-80BB47AE-E1F2-4BD2-80A5-741F6CD24363 Q36104887-EC2E2C81-9E77-45DB-B29F-C470B5583977 Q36716948-1439B2E6-F575-4E2B-9DC7-89AB85C55DA0 Q36910930-ADE166AD-9E3F-4C3D-90BF-5D30E2FE2089 Q37407778-E0CD5CCE-B0D6-4D65-A2F3-20320E7B5FBC Q37621547-2257045A-B8EA-4BC9-9173-270C02F846A7 Q37697926-3364DDB7-F031-467D-80A1-F2F2015612E9 Q37912038-7AE09BFE-04EB-4E36-82AC-A4364C7B6E07 Q38049170-BAB39F62-FE27-4371-8EA1-30503538383E Q38079128-3569E42D-76A4-457A-90FB-95867FD4E293 Q38092144-F3198C7A-27C1-4154-8476-75D8C9C14E4E Q38102603-7990FFA8-73A8-4605-B445-449526069218 Q38132834-A7C33536-3283-41F8-B5D7-8FCED8740E93 Q40335038-59F4C4CC-CC11-44FC-9B9B-AE06625B0839 Q40451914-5850CC44-4726-4239-81E0-54F7AFF9CA9F Q40930877-B58D22C2-5899-4ECC-948C-1B8389CDC75B Q41846974-B83DDD06-22E2-4C29-AC3B-2A0B2F397FF6 Q42123269-27C5457E-DEC9-4BCF-A704-11F210112F91 Q42233431-C06864F8-E8D0-4ACE-80C7-61663DB420A9 Q42735168-2BBA2959-372B-46FF-B482-3872DD402A53 Q42746251-04D55D25-D51A-4C86-BBD7-73CEB13113AE Q43427754-CB0463FF-8C25-4BE0-B343-0109C4C07546 Q46293116-FD365452-9A07-47E4-9B40-D8D42EF48C85 Q48226016-CE1C545C-9424-46DD-88DE-0283671FB8BA Q49136022-B1E874DF-2646-43CF-A7E8-989777E8E870 Q55509854-0EC546C5-E9D7-4E0E-8C6F-FE62572EA546 Q57216834-75E8FEB4-8B35-43FC-A262-C6BC984F709D Q57219101-A7290FCC-BB5E-4678-8788-00D0006BC29A

P2860

Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial

http://www.wikidata.org/entity/Q37042040

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lanthanum carbonate reduces ph ...... es 3 and 4: a randomized trial

@en

Lanthanum carbonate reduces ph ...... s 3 and 4: a randomized trial.

@nl

type

label

Lanthanum carbonate reduces ph ...... es 3 and 4: a randomized trial

@en

Lanthanum carbonate reduces ph ...... s 3 and 4: a randomized trial.

@nl

prefLabel

Lanthanum carbonate reduces ph ...... es 3 and 4: a randomized trial

@en

Lanthanum carbonate reduces ph ...... s 3 and 4: a randomized trial.

@nl

P1433

Q37042040-15E1E1AA-8E29-4292-8356-9730F08947B2

P1476

Q37042040-D5224FA4-3658-454F-A57A-B2590F0CF79D

P2093

Q37042040-328B903E-AECB-43AA-A33F-FDA9AB400E54

Q37042040-3321C925-904B-4FE9-8FEB-4A0266378BF6

Q37042040-38325CC6-D4D9-45FA-B657-1F8B754F3712

Q37042040-4A2B97AC-8D2C-46B4-A233-E338065ED7F1

Q37042040-9C89AB3C-E906-4388-992D-446F02EC3BFC

Q37042040-C1D8544B-6D7B-4A1E-9A29-6C89398E6D40

P2860

Q37042040-13B286CD-507E-49AB-ABFF-78EC001062B4

Q37042040-1751FC21-69F6-4E5E-811F-3CC36748E1E2

Q37042040-2C12D795-6992-4659-9B92-442B5E6F3A82

Q37042040-4148A8FD-B56F-4A24-BC91-C79BA83ABE43

Q37042040-450C1BE8-55F5-468C-BE76-20F007000EEB

Q37042040-557B476E-FBF0-41FE-9DE0-92A89EA5C940

Q37042040-6E7E77EC-1B62-4ADE-B7EA-C8EB1DE45EB0

Q37042040-709BDA78-FC30-4169-B820-9099B9DFC644

Q37042040-8F076039-0697-4460-82BB-A02E74CC3111

Q37042040-954E55F1-CE23-47D7-BAFA-1E5D2DD5F333

P304

Q37042040-34F3FDF2-BAA3-44B0-B3B8-2BE8B58BB4F8

P31

Q37042040-80C2F6F6-3063-42FF-A606-9BBCFE2A882E

P356

Q37042040-C68E7D00-5E7E-42CF-9352-E84DAA7D8035

P433

Q37042040-0703309F-2B37-4004-BF0F-773F4FDA367B

P478

Q37042040-0799AA6F-145E-4B4A-B55C-E016CE7F55F6

P577

Q37042040-56CDED71-BFDA-4A5C-85F6-906D5D9B8B42

P698

Q37042040-565F10E2-077E-430D-A224-FB3779CD5F2C

P921

Q37042040-C7B4CD8F-B35C-40DD-A31C-FB282414BEAF

P932

Q37042040-2B3DD153-E4FC-486E-AAB6-147674864422

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Lanthanum carbonate reduces ph ...... es 3 and 4: a randomized trial

@en

P2093

Hanna Abboud

http://www.w3.org/2001/XMLSchema#string

Matthew Dauphin

http://www.w3.org/2001/XMLSchema#string

Ping Qiu

http://www.w3.org/2001/XMLSchema#string

Pinggao Zhang

http://www.w3.org/2001/XMLSchema#string

Stuart M Sprague

http://www.w3.org/2001/XMLSchema#string

William Finn

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and mortality risk: a systematic review

Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers.

Normal mineral homeostasis. Interplay of parathyroid hormone and vitamin D.

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.

Lanthanum carbonate (Fosrenol) efficacy and tolerability in the treatment of hyperphosphatemic patients with end-stage renal disease.

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.

Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease.

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.

Efficacy and safety of lanthanum carbonate for reduction of serum phosphorus in patients with chronic renal failure receiving hemodialysis.

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

P304

178-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.02830608

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19056618

http://www.w3.org/2001/XMLSchema#string

P921

P932

2615694

http://www.w3.org/2001/XMLSchema#string